SIMONCINI, EDDA LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.170
EU - Europa 494
AS - Asia 186
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.856
Nazione #
US - Stati Uniti d'America 1.164
DE - Germania 168
CN - Cina 108
UA - Ucraina 92
IT - Italia 72
HK - Hong Kong 38
FI - Finlandia 37
RU - Federazione Russa 34
GB - Regno Unito 33
SG - Singapore 27
IE - Irlanda 22
CZ - Repubblica Ceca 15
FR - Francia 12
IN - India 11
CA - Canada 6
BE - Belgio 4
AU - Australia 3
BY - Bielorussia 1
CH - Svizzera 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IR - Iran 1
MU - Mauritius 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
Totale 1.856
Città #
Fairfield 193
Woodbridge 132
Ashburn 91
Chandler 88
Houston 72
Jacksonville 71
Cambridge 69
Seattle 66
Wilmington 64
Ann Arbor 59
New York 43
Hong Kong 38
Princeton 37
Beijing 28
Helsinki 25
Dublin 22
Boardman 19
Brescia 18
Dearborn 16
Nanjing 15
Singapore 15
Shanghai 12
Brno 11
Changsha 10
Munich 10
Milan 9
Nürnberg 9
Jinan 8
Nanchang 8
San Diego 8
Lancaster 7
Rome 7
Des Moines 6
London 6
Los Angeles 6
Mumbai 6
Jiaxing 5
Hebei 4
Olomouc 4
Shenyang 4
Toronto 4
Washington 4
Barberino di Mugello 3
Brussels 3
Genoa 3
Romola 3
San Mateo 3
Augusta 2
Canberra 2
Cornuda 2
Gradara 2
Haikou 2
Hangzhou 2
Lappeenranta 2
Ningbo 2
Orange 2
Ottawa 2
San Francisco 2
Tianjin 2
Ardabil 1
Belluno 1
Calcinato 1
Castel Colonna 1
Dietikon 1
Erbusco 1
Frankfurt am Main 1
Galati 1
Guangzhou 1
Hefei 1
Kilburn 1
Kocaeli 1
Lanzhou 1
Lviv 1
Magdeburg 1
Melbourne 1
Menen 1
Mogilëv 1
Nashville 1
Nave 1
New Bedfont 1
Pune 1
Strasbourg 1
Travagliato 1
Verona 1
Zhengzhou 1
Totale 1.394
Nome #
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 145
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 142
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 134
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 124
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 123
Exemestane with ovarian suppression in premenopausal breast cancer. 122
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 121
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 115
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 114
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 106
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 102
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 98
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 90
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 61
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 51
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data 49
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy 33
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 27
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 27
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 26
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 24
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 21
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 18
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 13
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 4
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 3
Totale 1.893
Categoria #
all - tutte 10.240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020374 0 0 14 45 31 53 46 47 46 59 9 24
2020/2021283 9 27 10 47 11 24 18 29 26 39 34 9
2021/2022172 27 14 7 5 2 9 3 14 7 24 8 52
2022/2023227 22 8 5 13 26 53 0 30 36 2 19 13
2023/2024284 18 5 30 6 18 57 14 8 45 6 6 71
2024/202519 6 6 7 0 0 0 0 0 0 0 0 0
Totale 1.893